Halkin H - Search Results

1

The implementation of managed care for diabetes using medical informatics in a large Preferred Provider Organization.

Heymann AD, Chodick G, Halkin H, Karasik A, Shalev V, Shemer J, Kokia E. Heymann AD, et al. Among authors: halkin h. Diabetes Res Clin Pract. 2006 Mar;71(3):290-8. doi: 10.1016/j.diabres.2005.07.002. Epub 2005 Aug 19. Diabetes Res Clin Pract. 2006. PMID: 16112245

2

[Description of a diabetes disease register extracted from a central database].

Heymann AD, Chodick G, Halkin H, Kokia E, Shalev V. Heymann AD, et al. Among authors: halkin h. Harefuah. 2007 Jan;146(1):15-7, 79. Harefuah. 2007. PMID: 17294841 Hebrew.

3

Increased warfarin doses and decreased international normalized ratio response after nationwide generic switching.

Halkin H, Shapiro J, Kurnik D, Loebstein R, Shalev V, Kokia E. Halkin H, et al. Clin Pharmacol Ther. 2003 Sep;74(3):215-21. doi: 10.1016/S0009-9236(03)00166-8. Clin Pharmacol Ther. 2003. PMID: 12966365

4

Database evaluation of the effects of long-term rosiglitazone treatment on cardiovascular outcomes in patients with type 2 diabetes.

Loebstein R, Dushinat M, Vesterman-Landes J, Silverman B, Friedman N, Katzir I, Kurnik D, Lomnicky Y, Kokia E, Halkin H. Loebstein R, et al. Among authors: halkin h. J Clin Pharmacol. 2011 Feb;51(2):173-80. doi: 10.1177/0091270010368281. Epub 2010 May 19. J Clin Pharmacol. 2011. PMID: 20484611

5

Brand versus generic alendronate: gastrointestinal effects measured by resource utilization.

Halkin H, Dushenat M, Silverman B, Shalev V, Loebstein R, Lomnicky Y, Friedman N. Halkin H, et al. Ann Pharmacother. 2007 Jan;41(1):29-34. doi: 10.1345/aph.1H218. Epub 2006 Dec 26. Ann Pharmacother. 2007. PMID: 17190847

6

Elevated serum uric acid--a facet of hyperinsulinaemia.

Modan M, Halkin H, Karasik A, Lusky A. Modan M, et al. Among authors: halkin h. Diabetologia. 1987 Sep;30(9):713-8. doi: 10.1007/BF00296994. Diabetologia. 1987. PMID: 3322912

7

[Generic drug substitution].

Tamir O, Halkin H, Shemer J. Tamir O, et al. Among authors: halkin h. Harefuah. 2006 Sep;145(9):691-5, 701. Harefuah. 2006. PMID: 17078434 Hebrew.

8

Effectiveness of glycosylated hemoglobin, fasting plasma glucose, and a single post load plasma glucose level in population screening for glucose intolerance.

Modan M, Halkin H, Karasik A, Lusky A. Modan M, et al. Among authors: halkin h. Am J Epidemiol. 1984 Mar;119(3):431-44. doi: 10.1093/oxfordjournals.aje.a113761. Am J Epidemiol. 1984. PMID: 6702817

9

Senile cataract and glucose intolerance: the Israel Study of glucose Intolerance Obesity and Hypertension (The Israel GOH Study).

Karasik A, Modan M, Halkin H, Treister G, Fuchs Z, Lusky A. Karasik A, et al. Among authors: halkin h. Diabetes Care. 1984 Jan-Feb;7(1):52-6. doi: 10.2337/diacare.7.1.52. Diabetes Care. 1984. PMID: 6705665

10

Hyperinsulinemia, sex, and risk of atherosclerotic cardiovascular disease.

Modan M, Or J, Karasik A, Drory Y, Fuchs Z, Lusky A, Chetrit A, Halkin H. Modan M, et al. Among authors: halkin h. Circulation. 1991 Sep;84(3):1165-75. doi: 10.1161/01.cir.84.3.1165. Circulation. 1991. PMID: 1884447

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

153 results

Search Page

Filters